These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37329534)
1. LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis. Geng Y; Chen P; Zhang L; Li X; Song C; Wei X; Gong H Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):133-140. PubMed ID: 37329534 [TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Cell Proliferation and Migration by Regulating miR-143-3p and MAGE Family Member A9 (MAGEA9) in Oral Squamous Cell Carcinoma. Yu L; Shao X; Huo L; Zhang T Med Sci Monit; 2020 Sep; 26():e924187. PubMed ID: 32879299 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. Yue X; Wu WY; Dong M; Guo M Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis. Wei S; Wang K; Huang X; Zhao Z; Zhao Z Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression. Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging. Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053 [TBL] [Abstract][Full Text] [Related]
7. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma. Wang Z; Chang X; Zhu G; Gao X; Chang L Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095 [TBL] [Abstract][Full Text] [Related]
8. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis. Li Q; Dai Z; Xia C; Jin L; Chen X Mol Cell Biochem; 2020 Jul; 470(1-2):165-174. PubMed ID: 32468237 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1. Gou L; Zou H; Li B Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506 [TBL] [Abstract][Full Text] [Related]
10. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis. Sun T; Song Y; Yu H; Luo X Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442 [TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis. Luo L; Wang Y; Hu P; Wu J Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724 [TBL] [Abstract][Full Text] [Related]
12. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809 [TBL] [Abstract][Full Text] [Related]
13. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis. Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Sun R; Zhang L Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1. Liu X; Zhao W; Wang X Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391 [TBL] [Abstract][Full Text] [Related]
16. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766 [TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression. Chen L; Yao H; Wang K; Liu X J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721 [TBL] [Abstract][Full Text] [Related]
18. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma. Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138 [TBL] [Abstract][Full Text] [Related]
19. MALAT1 accelerates proliferation and inflammation and suppresses apoptosis of endometrial stromal cells via the microRNA-142-3p/CXCR7 axis. Tan K; Mo H; Guo L; Wang B Reprod Biol; 2022 Sep; 22(3):100675. PubMed ID: 35901619 [TBL] [Abstract][Full Text] [Related]
20. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]